⌘K
t
On 20 June 2022, Douglas Benzie, Chief Financial Officer of Barkby Group PLC, transferred 833,334 ordinary shares from being held in his own name to being held in his self-invested personal pension (SIPP). Following this transfer, Mr. Benzie's total beneficial interest in the company remains 833,334 ordinary shares, representing approximately 0.58% of Barkby Group PLC's issued share capital.
| Date | 21 Jun 2022 |
| Time | 15:19:30 |
| Category | Director/PDMR dealings |
| ID | 6815P |
21 June 2022
Barkby Group PLC
("Barkby" or the "Company")
Director/PDMR Shareholding
Barkby Group PLC was notified on 20 June 2022 that on the same day, Douglas Benzie, Chief Financial Officer of the Company, had transferred via sale and purchase (the "Transfer") 833,334 ordinary shares of £0.00860675675675676 each in the Company ("Ordinary Shares") from being held in his own name to being held in his self-invested personal pension ("SIPP").
Following the completion of the Transfer, there will be no change to Mr Benzie's total beneficial interest in the Company, being 833,334 Ordinary Shares representing approximately 0.58% of the Company's issued share capital.
Enquiries:
|
Barkby Group plc Charles Dickson (Executive Chairman) Douglas Benzie (CFO)
|
via Camarco |
|
finnCap Ltd (Nomad and Broker) Carl Holmes/Simon Hicks (corporate finance) Tim Redfern/Richard Chambers (ECM)
|
+44 (0) 20 7220 0500 |
|
Camarco (Financial PR) Jennifer Renwick/Phoebe Pugh |
+44 (0) 20 3757 4994 |
Notes to editors
About The Barkby Group Plc:
Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses units within Barkby include: Barkby Real Estate, Barkby Pub Co. and Barkby Investments (comprising of Workshop Coffee, Centurian Automotive, Cambridge Sleep Sciences and a minority stake in Verso Biosense).
Barkby's strategy is to accelerate and maximise opportunities within its existing businesses.
The Notification of Dealing Forms set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||||||||
|
a) |
Name: |
Douglas Alexander Benzie |
|||||||||
|
2. |
Reason for the notification |
||||||||||
|
a) |
Position/status: |
Chief Financial Officer |
|||||||||
|
b) |
Initial notification/Amendment: |
Initial Notification |
|||||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||
|
a) |
Name: |
Barkby Group plc |
|||||||||
|
b) |
LEI: |
213800X57YXZVILB9E84 |
|||||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||
|
a) |
Description of the financial instrument, type of instrument: Identification code: |
Ordinary Shares of £0.00860675675675676 GB00BL6TZZ70 |
|||||||||
|
b) |
Nature of the transaction: |
Transfer via sale and purchase of Ordinary Shares |
|||||||||
|
c) |
Price(s) and volume(s): |
|
|||||||||
|
d) |
Aggregated information: · Aggregated volume: · Price: |
N/A |
|||||||||
|
e) |
Date of the transaction: |
20 June 2022 |
|||||||||
|
f) |
Place of the transaction: |
London Stock Exchange, AIM Market (XLON) |
|||||||||